A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Foundation IRCCS Polyclinic San Matteo
This publication has 31 references indexed in Scilit:
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Immune-checkpoint inhibitors: long-term implications of toxicityNature Reviews Clinical Oncology, 2022
- ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical TreatmentJournal of Crohn's and Colitis, 2021
- Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategiesNature Reviews Drug Discovery, 2021
- AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert ReviewGastroenterology, 2021
- Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?British Journal of Cancer, 2020
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillanceNature Reviews Clinical Oncology, 2019
- Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitisNature Medicine, 2018
- Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: A systematic review and meta-analysisOncoImmunology, 2017
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987